AFRICA: Johnson & Johnson and global partners have announced the discontinuation of the Imbokodo study of HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa.
The clinical...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkNoPrivacy policy
